Loss of Transcription Factor ATOH8 Activates TGF-β Signaling and Exacerbates Glomerulosclerosis in Podocytes

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/c7f26ae05b9b109079dfc3385d0d8d3e.pdf
Loss of Transcription Factor ATOH8 Activates TGF-β Signaling and Exacerbates Glomerulosclerosis in Podocytes

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Hiroko
Hamatani
Hiroko Hamatani hamatani@gunma-u.ac.jp Gunma University Graduate School of Medicine Department of Nephrology and Rheumatology Maebashi Japan *
Akifumi Tabei eetabei@gmail.com Gunma University Graduate School of Medicine Department of Nephrology and Rheumatology Maebashi Japan -
Shinichiro Ogawa ogashin0001@gmail.com Gunma University Graduate School of Medicine Department of Nephrology and Rheumatology Maebashi Japan -
Junya Suwa m15702047@gunma-u.ac.jp Gunma University Graduate School of Medicine Department of Nephrology and Rheumatology Maebashi Japan -
Rei Ishihara ishihara@shoken-gakuen.ac.jp Gunma University of Health and Welfare Faculty of Medical Technology and Clinical Engineering Maebashi Japan -
Yuki Murakami y-murakami@shoken-gakuen.ac.jp Gunma University of Health and Welfare Faculty of Medical Technology and Clinical Engineering Maebashi Japan -
Toru Sakairi torusaka@gmail.com Gunma University Graduate School of Medicine Department of Nephrology and Rheumatology Maebashi Japan -
Hidekazu Ikeuchi hikeuchi@gunma-u.ac.jp Gunma University Graduate School of Medicine Department of Nephrology and Rheumatology Maebashi Japan -
Yoriaki Kaneko kaneko_yoriaki@gunma-u.ac.jp Gunma University Graduate School of Medicine Department of Nephrology and Rheumatology Maebashi Japan -
Hiroshi Handa handahiroshi@gunma-u.ac.jp Gunma University Graduate School of Medicine Department of Hematology Maebashi Japan -
Masato Morikawa morikawa-tky@umin.ac.jp Teikyo University, Advanced Comprehensive Research Organization (ACRO) Division of Health Science Itabashi-ku Japan -
Keiju Hiromura hiromura@gunma-u.ac.jp Gunma University Graduate School of Medicine Department of Nephrology and Rheumatology Maebashi Japan -
-
-
-